Gout, characterised by elevated blood uric acid levels, is a crystalline arthropathy due to monosodium urate deposition and is closely related to hyperuricemia, with a complex pathogenesis, numerous complications, and an increasing and gradually younger incidence worldwide, which has become an important public health problem. In recent years, there have been more and more researches on the treatment of gout by traditional Chinese medicine. In addition to the use of traditional Chinese medicinal herbs, Tibetan, Mongolian, Zhuang, and Miao doctors also have rich clinical experience in the treatment of gout by using ethnic speciality herbs. This article reviews the research progress of Chinese medicine for gout in the last five years, with a view to providing references for future clinical practice.

1.Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors[J]. Nat Rev Rheumatol, 2020, 16(7): 380-390. DOI: 10.1038/s41584-020-0441-1.

2.杨丽华, 刘晓丽, 蒋雅琼, 等. 我国痛风的患病率及危险因素[J]. 医学研究杂志, 2019, 48(12): 4-6, 10. [Yang LH, Liu XL, Jiang YQ, et al. Prevalence and risk factors of gout in China[J]. Journal of Medical Research, 2019, 48(12): 4-6, 10.] DOI: 10.11969/j.issn.1673-548X. 2019.12.002.

3.黄叶飞, 杨克虎, 陈澍洪, 等. 高尿酸血症/痛风患者实践指南[J]. 中华内科杂志, 2020, 59(7): 519-527. [Huang YF, Yang KH, Chen SH, et al. Practice guideline for patients with hyperuricemia/gout[J]. Chinese Journal of Internal Medicine, 2020, 59(7): 519-527.] DOI: 10.3760/cma.j.cn112138-20200505-00449.

4.中华医学会内分泌学会. 《中国高尿酸血症与痛风诊疗指南》(2019)[EB/OL]. (2020-01-30) [2024-12-16]. https://d.wanfangdata.com.cn/ Periodical/zhnfmdx202001003.

5.Huang J, Ma ZF, Zhang Y, et al. Geographical distribution of hyperuricemia in mainland China: a comprehensive systematic review and meta-analysis[J]. Global Health Res Policy, 2020, 5(1): 52. DOI: 10.1186/s41256-020-00178-9.

6.Kuwabara M, Niwa K, Nishi Y, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension[J]. Hypertens Res, 2014, 37(8): 785-789. DOI: 10.1038/hr.2014.75.

7.Ponticelli C, Podestà MA, Moroni G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease[J]. Kidney Int, 2020, 98(5): 1149-1159. DOI: 10.1016/j.kint.2020.05.056.

8.方海琴, 姜萍, 王永俊, 等. 成人高尿酸血症与痛风食养指南（2024年版）[J]. 卫生研究, 2024, 53(3): 352-356. [Fang HQ, Jiang P, Wang YJ, et al. Dietary guidelines for hyperuricemia and gout in adults (2024 edition)[J]. Journal of Hygiene Research, 2024, 53(3): 352-356.] DOI: 10.19813/j.cnki.weishengyanjiu.2024.03.002.

9.Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism[J]. Hypertension, 2001, 38(5): 1101-1106. DOI: 10.1161/hy1101.092839.

10.Biscaglia S, Ceconi C, Malagù M, et al. Uric acid and coronary artery disease: an elusive link deserving further attention[J]. Int J Cardiol, 2016, 213: 28-32. DOI: 10.1016/j.ijcard.2015.08.086.

11.Mazumder R, Jaiswal AK, Sharma A. Natural bioactives in the management of hyperuricemia: a challenge to gout therapy[J]. Int J Health Sci, 2022, 6(S4): 10092-10108. DOI: 10.53730/ijhs.v6nS4.11290.

12.Chen CH, Chen CB, Chang CJ, et al. Hypersensitivity and cardiovascular risks related to allopurinol and febuxostat therapy in asians: a population-based cohort study and Meta-analysis[J]. Clin Pharmacol Ther, 2019, 106(2): 391-401. DOI: 10.1002/cpt.1377.

13.袁红宇, 何苗, 欧宁. 中药治疗痛风临床疗效Meta分析[J]. 中华中医药学刊, 2011, 29(3): 666-670. [Yuan HY, He M, Ou  N. Meta-analysis on clinical therapeutic effects of TCM on gout[J]. Chinese Archives of Traditional Chinese Medicine, 2011, 29(3): 666-670.] DOI: 10.13193/j.archtcm.2011.03.220.yuanhy.013.

14.国家卫生健康委办公厅. 国家卫生健康委办公厅印发成人高尿酸血症与痛风食养指南（2024年版）等4项食养指南[J]. 上海护理, 2024, 24(3): 71. [General Office of the National Health Commission. The general office of the national health commission issued four dietary guidelines for adults with hyperuricemia and gout (2024 version)[J]. Shanghai Nursing, 2024, 24(3): 71.] DOI: 10.3969/j.issn.1009-8399.2024.03.019.

15.刘维. 痛风及高尿酸血症中西医结合诊疗指南[J]. 中医杂志, 2023, 64(1): 98-106. [Liu W. Guideline for diagnosis and treatment of gout and hyperuricemia with integrated traditional Chinese and western medicine[J]. Journal of Traditional Chinese Medicine, 2023, 64(1): 98-106.] DOI: 10.13288/j.11-2166/r.2023.01.019.

16.Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout classification criteria: an american college of rheumatology/european league against rheumatism collaborative initiative[J]. Ann Rheum Dis, 2015, 74(10): 1789-1798. DOI: 10.1136/annrheumdis-2015-208237.

17.张博超, 马斌鸿, 王圆, 等. 郭俊杰从五期四证论治痛风经验[J]. 湖南中医杂志, 2024, 40(7): 61-65. [Zhang BC, Ma BH, Wang Y, et al. Guo Junjie's experience in treating gout from five phases and four evidence-based treatments[J]. Hunan Journal of Traditional Chinese Medicine, 2024, 40(7): 61-65.] DOI: 10.16808/j.cnki.issn1003-7705.2024.07.015.

18.黄宇涵, 徐莎, 房伟, 等. 玉米须总黄酮抗大鼠高尿酸血症及肾脏保护作用[J]. 郑州大学学报（医学版）, 2024, 59(1): 45-50. [Huang YH, Xu S, Fang W. Anti-hyperuricemia and renal protection effects of total flavonoids from corn silk[J]. Journal of Zhengzhou University (Medical Sciences), 2024, 59(1): 45-50.] DOI: 10.13705/j.issn.1671-6825.2023.03.028.

19.李琪, 幸鸿雁, 李伟坤, 等. 秦艽根和玉米须提取物对高尿酸血症大鼠的治疗效果研究[J]. 生物化工, 2024, 10(3): 54-56, 60. [Li Q, Xin HY, Li WK, et al. Study on the therapeutic effect of the extract of the root of gentiana macrophylla and stigmata maydis on hyperuricemia rats[J]. Biological Chemical Engineering, 2024, 10(3): 54-56, 60.] DOI: 10.3969/j.issn.2096-0387.2024.03.010.

20.Liu L, Jiang S, Liu X, et al. Inflammatory response and oxidative stress as mechanism of reducing hyperuricemia of gardenia jasminoides-poria cocos with network pharmacology[J]. Oxid Med Cell Longev, 2021, 2021: 8031319. DOI: 10.1155/2021/8031319.

21.王娟, 许兵兵, 曾金祥, 等. 车前子中黄嘌呤氧化酶抑制剂成分的电化学生物传感筛选研究[J]. 药物分析杂志, 2017, 37(7): 1215-1222. [Wang J, Xu BB, Zeng JX, et al. Screening of xanthine oxidase inhibitors from plantaginis semen using electrochemical biosensor method[J]. Chinese Journal of Pharmaceutical Analysis, 2017, 37(7): 1215-1222.] DOI: 10.16155/j.0254-1793.2017.07.08.

22.赵宏, 柴桂芳, 刘颖斐, 等. 车前子水煎液对痛风性肾病大鼠的肾保护作用及机制[J]. 中国实验方剂学杂志, 2018, 24(20): 108-114. [Zhao H, Chai GF, Liu YF. et al. Renal protective effect and preliminary mechanism of water decoction from plantaginis semen on rats with gouty nephropathy[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24(20): 108-114.] DOI: 10.13422/j.cnki.syfjx.20182035.

23.任丽, 欧水平, 陈灵, 等. 虎杖提取物及其有效部位的大鼠抗痛风性关节炎试验[J]. 中国实验方剂学杂志, 2016, 22(19): 111-115. [Ren L, Ou SP, Chen L, et al. Anti-gouty arthritis test in rats of polygoni cuspidati rhizoma et radix extract and its effective parts[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(19): 111-115.] DOI: 10.13422/j.cnki.syfjx.2016190111.

24.叶茂高. 虎杖对高尿酸血症大鼠肾小管尿酸转运蛋白表达的影响[J]. 浙江中医杂志, 2019, 54(12): 917-919. [Ye MG. Effect of polygonum cuspidatum on hyperuricemia rat renal urate transporter expression[J]. Zhejiang Journal of Traditional Chinese Medicine, 2019, 54(12): 917-919.] DOI: 10.13633/j.cnki.zjtcm.2019.12.037.

25.庄丹, 秦靖, 王慧阳, 等. 苍术的药效成分研究进展[J]. 生物加工过程, 2021, 19(3): 306-313. [Zhuang D, Qin J, Wang HY, et al. Medicinal compositions of Atractylodis rhizoma: a review[J]. Chinese Journal of Bioprocess Engineering, 2021, 19(3): 306-313.] DOI: 10.3969/j.issn.1672-3678.2021.03.012.

26.刘晋利, 王好宁, 周鲁川. 加味苍术泄浊饮对高尿酸血症患者尿酸及血脂水平的影响[J]. 中国药业, 2024, 33(16): 113-116. [Liu JL, Wang HN, Zhou LC. Effects of modified cangzhu xiezhuo drink on uric acid and blood lipid levels in patients with hyperuricemia[J]. China Pharmaceuticals, 2024, 33(16): 113-116.] DOI: 10.3969/j.issn.1006-4931.2024.16.027.

27.刘亚飞, 陈哲, 涂胜豪. 加味四妙方对高尿酸血症合并急性痛风性关节炎模型大鼠踝关节组织NLRP3 mRNA及IL-1β、TNF-α表达的影响[J]. 中医杂志, 2020, 61(14): 1268-1272. [Liu YF, Chen Z, Tu SH. Effects of modified simiao decoction on the expression of NLRP3 mRNA, IL-1β, TNF-α in ankle joints tissue of hyperuricemia model rats combined with acute gouty arthritis[J]. Journal of Traditional Chinese Medicine, 2020, 61(14): 1268-1272.] DOI: 10.13288/j.11-2166/r.2020.14.017.

28.Qian X, Jiang Y, Luo Y, et al. The Anti-hyperuricemia and anti-inflammatory effects of atractylodes macrocephala in hyperuricemia and gouty arthritis rat models[J]. Comb Chem High Throughput Screen, 2023, 26(5): 950-964. DOI: 10.2174/1386207325666220603101540.

29.王特, 张晓宇, 张薇, 等. 土茯苓防治痛风的作用机制研究进展[J]. 辽宁中医杂志, 2021, 48(1): 215-217. [Wang T, Zhang  XY, Zhang W, et al. Research progress of mechanism of tufingling (rhizoma smilacis glabrae) in treating gout[J]. Liaoning Journal of Traditional Chinese Medicine, 2021, 48(1): 215-217.] DOI: 10.13192/j.issn.1000-1719.2021.01.060.

30.刘顺, 李赫宇, 赵玲. 白藜芦醇降血尿酸、抗炎作用研究进展 [J]. 药物评价研究, 2016, 39(2): 304-307. [Liu S, Li HY, Zhao  L. Research progress on lowering uric acid and anti-inflammation effect of resveratrol[J]. Drug Evaluation Research, 2016, 39(2): 304-307.] DOI: 10.7501/j.issn.1674-6376.2016.02.031.

31.彭嘉文, 谢晶晶, 马玉明, 等. 土茯苓的质量控制现状及质量标志物预测分析[J]. 中华中医药学刊, 2025, 43(4): 181-186. [Peng  JW, Xie  JJ, Ma YM, et al. Quality control status and prediction analysis of quality markers of smilacis glabrae rhizoma[J]. Chinese Archives of Traditional Chinese Medicine, 2025, 43(4): 181-186.] DOI: 10.13193/j.issn.1673-7717.2025.04.029.

32.赵梓童, 年四辉, 孙绪强, 等. 茯苓皮提取物对高尿酸血症小鼠的尿酸水平和肾脏的影响[J]. 海南医学院学报, 2023, 29(3): 168-174. [Zhao ZT, Nian SH, Sun XQ, et al. Study on the effect of lowering uric acid and effect on the kidney of Poriae cutis in hyperuricemia mice[J]. Journal of Hainan Medical University, 2023, 29(3): 168-174.] DOI: 10.13210/j.cnki.jhmu.20221205.001.

33.李敏, 全云云, 王婷, 等. 川黄柏及其活性成分治疗痛风病作用研究进展[J]. 中国实验方剂学杂志, 2024, 30(1): 286-298. [Li M, Quan YY, Wang T, et al. Pharmacological effect of phellodendri Chinensis cortex and active components on gout: a review[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30(1): 286-298.] DOI: 10.13422/j.cnki.syfjx.20231119.

34.王爱华, 金玥, 吴越, 等. 具有黄嘌呤氧化酶抑制作用的中药及中成药治疗高尿酸血症研究进展[J]. 天津中医药, 2019, 36(12): 1241-1245. [Wang AH, Jin Y, Wu Y, et al. Research progress on treatment of gout by xanthine oxidase inhibitor in traditional Chinese medicine[J]. Tianjin Journal of Traditional Chinese Medicine, 2019, 36(12): 1241-1245.] DOI: 10.11656/j.issn.1672-1519.2019.12.23.

35.Lin G, Yu Q, Xu L, et al. Berberrubine attenuates potassium oxonate-and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway[J]. Eur J Pharm, 2021, 912: 174592. DOI: 10.1016/j.ejphar.2021.174592.

36.吕耀中, 胡庆华, 王星, 等. 二妙丸水提取物对高尿酸血症小鼠尿酸失衡及其相关基因和蛋白水平的影响[J]. 中草药, 2010, 41(3): 418-423. [Lyu YZ, Hu QH, Wang X, et al. Effects of Ermiao Pill water extracts on imbalance of urate levels and its related genes and protein levels in hyperuricemic mice[J]. Chinese Traditional and Herbal Drugs, 2010, 41(3): 418-423.] https://www.cnki.com.cn/Article/ CJFDTOTAL-ZCYO201003031.htm.

37.刘悦. 小檗碱及其衍生物抗痛风作用研究[D]. 黑龙江佳木斯: 佳木斯大学, 2015. https://cdmd.cnki.com.cn/ Article/CDMD-10227-1014087032.htm.

38.朱立然. 萆薢总皂苷对高尿酸血症大鼠尿酸转运蛋白表达的影响[D]. 合肥: 安徽中医药大学, 2014. https://cdmd.cnki.com.cn/ Article/CDMD-10369-1014172647.htm.

39.李国莺, 章维志, 姜璐, 等. 萆薢总皂苷对尿酸钠诱导THP-1细胞Toll样受体/核转录因子-κB（TLR/NF-κB）信号通路的影响[J]. 中国实验方剂学杂志, 2020, 26(5): 34-41. [Li  GY, Zhang WZ, Jiang L, et al. Effect of total saponin of dioscoreae collettii rhizoma on toll-like receptor/nuclear factor-κB (TLR/NF-κB) Signaling pathway induced by monosodium urate in THP-1 cells[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2020, 26(5): 34-41.] DOI: 10.13422/j.cnki.syfjx.20200401.

40.康乐, 苗艳艳, 苗明三, 等. 基于调控尿酸转运蛋白的牛膝茎叶总皂苷治疗高尿酸血症肾病大鼠机制研究[J]. 中华中医药杂志, 2020, 35(5): 2305-2310. [Kang L, Miao YY, Miao MS, et al. Mechanism of total saponins from stem and leaf of Achyranthes bidentata Bl. in treating rats with hyperuricemic nephropathy[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2020, 35(5): 2305-2310.] https://d.wanfangdata.com.cn/conference/ChZDb25mZXJlbmNlTmV3UzIwMjUwNjI3EggxMDgxNjA0NRoIYmsza2F0Y3k%3D.

41.Huang J, Lin Z, Wang Y, et al. Wuling san based on network pharmacology and in vivo evidence against hyperuricemia via improving oxidative stress and inhibiting inflammation[J]. Drug Design Devel Ther, 2023, 17: 675-690. DOI: 10.2147/DDDT.S398625.

42.刘涛. 薏仁木瓜化浊汤对高尿酸血症小鼠的降尿酸作用及其机制研究[D]. 广州: 广东药科大学, 2021. https://cdmd.cnki.com.cn/Article/CDMD-10573-1020391820.htm.

43.Ma CH, Kang LL, Ren HM, et al. Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in high fructose-fed rats[J]. J  Ethnopharm, 2015, 172: 108-117. DOI: 10.1016/j.jep.2015.06.015.

44.Liu YF, Tu SH, Chen Z, et al. Effects of modified simiao decoction on il-1β and TNF α secretion in monocytic THP-1 cells with monosodium urate crystals-induced inflammation[J]. Evid Based Complement Alternat Med, 2014, 2014: 406816. DOI: 10.1155/2014/406816.

45.林彤, 李丽, 梁彩君, 等. 四妙散治疗肾病综合征、痛风及湿疹的系统生物学研究[J]. 中医药导报, 2020, 26(13): 124-128, 175. [Lin T, Li L, Liang CJ, et al. A systematic biology study of simiao decoction for treating different diseases with the same method on nephrotic syndrome, gout, and eczema[J]. Guiding Journal of Traditional Chinese Medicine and Pharmacology, 2020, 26(13): 124-128, 175.] DOI: 10.13862/j.cnki.cn43-1446/r.2020.13.029.

46.钟宜腾, 朱英. 四妙散治疗急性痛风性关节炎的药理、临床及实验研究进展[J]. 世界中医药, 2024, 19(6): 904-909. [Zhong  YT, Zhu Y. Progress in pharmacology, clinical and experimental research on the treatment of acute gouty arthritis with simiao powder[J]. World Chinese Medicine, 2024, 19(6): 904-909.] DOI: 10.3969/j.issn.1673-7202.2024.06.025.

47.Hua J, Huang P, Zhu CM, et al. Anti-hyperuricemic and nephroprotective effects of modified simiao decoction in hyperuricemic mice[J]. J Ethnopharm, 2012, 142(1): 248-252. DOI: 10.1016/j.jep.2012.04.052.

48.罗书曼, 朱星, 陈帅, 等. 四妙汤对类风湿关节炎大鼠维生素D系统及中性粒细胞胞外诱捕网的影响研究[J]. 中国全科医学, 2024, 27(3): 348-356. [Luo SM, Zhu X, Chen S, et al. Effect of Simiao Decoction on vitamin D system and neutrophil extracellular traps in rats with rheumatoid arthritis[J]. Chinese General Practice, 2024, 27(3): 348-356.] DOI: 10.12114/j.issn.1007-9572.2023.0328.

49.Lin X, Shao T, Huang L, et al. Simiao decoction alleviates gouty arthritis by modulating proinflammatory cytokines and the gut ecosystem[J]. Front Pharmacol, 2020, 11: 955. DOI: 10.3389/fphar.2020.00955.

50.徐少晶, 史家毓, 徐子昱, 等. 宣痹汤通过调控COX-2信号通路抑制大鼠急性痛风性关节炎炎症反应的机制研究[J]. 中国免疫学杂志, 2024, 40(5): 1069-1074. [Xu SJ, Shi JY, Xu  ZY, et al. Mechanism of Xuan Bi decoction inhibiting acute gouty arthritis response in rats by regulating COX-2 signal pathway[J]. Chinese Journal of Immunology, 2024, 40(5): 1069-1074.] DOI: 10.3969/j.issn.1000-484X.2024. 05.025.

51.Song S, Fan M, Wen X, et al. Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-Bi decoction against hyperuricemia and gout[J]. J Ethnopharm, 2023, 316: 116736. DOI: 10.1016/j.jep.2023.116736.

52.Wen X, Lou Y, Song S, et al. Qu-Zhuo-Tong-Bi decoction alleviates gouty arthritis by regulating butyrate-producing bacteria in mice[J]. Front Pharmacol, 2020, 11: 610556. DOI: 10.3389/fphar.2020.610556.

53.李建, 张洁瑛, 孙鹏, 等. 平胃散合桂枝芍药知母汤加减治疗慢性痛风性关节炎的疗效机制[J]. 中国实验方剂学杂志, 2018, 24(1): 180-185. [Li J, Zhang JY, Sun P, et al. Clinical efficacy of addition and subtraction treatment of Pingweisan combined with Guizhi Shaoyao Zhimu Tang for chronic gouty arthritis[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2018, 24(1): 180-185.] DOI: 10.13422/j.cnki.syfjx.2018010180.

54.杨晓凌, 刘欢, 陈亮, 等. 防己黄芪汤与非布司他对脾虚湿阻型痛风性关节炎的疗效[J]. 中国继续医学教育, 2018, 10(25): 142-144. [Yang XL, Liu H, Chen L, et al. The curative effect of Fangjihuangqi decoction and Febuxostat on the gouty arthritis of spleen deficiency[J]. China Continuing Medical Education, 2018, 10(25): 142-144.] DOI: 10.3969/j.issn.1674-9308.2018.25.074.

55.刘贵昌, 张淑蓉, 吴婷, 等. 防己黄芪汤中多糖的提取及含量测定研究[J].中国药物与临床, 2017, 17(8): 1153-1154. [Liu  GC, Zhang SR, Wu T, et al. Extraction and content determination of polysaccharides in Fangji Huangqi Tang[J]. Chinese Remedies & Clinics, 2017, 17(8): 1153-1154.] DOI: 10.11655/zgywylc2017.08.019.

56.王蓉, 马腾茂, 刘飞, 等. 防己的药理作用及临床应用研究进展[J].中国中药杂志, 2017, 42(4): 634-639. [Wang R, Ma  TM, Liu F, et al. Research progress on pharmacological action and clinical application of stephania tetrandrae radix[J]. China Journal of Chinese Materia Medica, 2017, 42(4): 634-639.] DOI: 10.19540/j.cnki.cjcmm.20170121.024.

57.王腾腾, 陈岩, 李金龙, 等. 防己黄芪汤通过促进淋巴管生成及回流功能改善关节肿胀的研究[J].中华中医药杂志, 2017, 32(5): 1961-1965. [Wang TT, Chen Y, Li JL, et al. Study on alleviating joint swelling by promoting lymphatic drainage and lymphangion genesis by Fangji Huangqi decoction[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2017, 32(5):1961-1965.] https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201705016.htm.

58.韩洁茹, 解颖, 陈飞, 等. 资生肾气丸对痛风大鼠GSH、NF-κΒ表达水平的影响[J]. 世界中医药, 2019, 14(12): 3178-3181. [Han JR, Xie Y, Chen F, et al. Effects of Zisheng Shenqi pills on expression of GSH and NF-κΒ in gouty rats[J]. World Chinese Medicine, 2019, 14(12): 3178-3181.] DOI: 10.3969/j.issn.1673-7202.2019.12.017.

59.汪永辉, 萧闵, 李瑛, 等. 参苓白术散调节AMPK、ABCG2改善高尿酸血症模型小鼠尿酸的实验研究[J].湖南中医药大学学报, 2022, 42(12): 1982-1987. [Wang YH, Xiao M, Li  Y, et al. Experimental study on Shenling Baizhu Powder's effects on uric acid in hyperuricemia model mice through AMPK and ABCG2[J]. Journal of Traditional Chinese Medicine University of Hunan, 2022, 42(12): 1982-1987.] DOI: 10.3969/j.issn.1674-070X.2022.12.005.

60.Amatjan M, Li N, He P, et al. A novel approach based on gut microbiota analysis and network pharmacology to explain the mechanisms of action of cichorium intybus L. formula in the improvement of hyperuricemic nephropathy in rats[J]. Drug Design Devel Ther, 2023, 17: 107-128. DOI: 10.2147/DDDT.S389811.

61.李敏, 郎吉瑞, 李延芳, 等. 痛风和高尿酸血症的藏医药治疗研究进展[J]. 中药药理与临床, 2024, 40(11): 120-128. [Li  M, Lang JR, Li YF, et al. Research Progress of Tibetan Medicine in the Treatment of Gout and Hyperuricemia[J]. Pharmacology and Clinics of Chinese Materia Medica, 2024, 40(11): 120-128.] DOI: 10.13412/j.cnki.zyyl.20240912.006.

62.玛久措, 夏吾李先. 藏药二十五味驴血丸治疗痛风病的疗效观察[J]. 世界最新医学信息文摘, 2019, 19(25): 145. [Ma JC, Xia WLX. Observations on the therapeutic effect of Twenty-five-flavour Donkey's Blood Pill of Tibetan medicine in the treatment of gout disease[J]. World Latest Medicine Information, 2019, 19(25): 145.] DOI: 10.19613/j.cnki.1671-3141.2019.25.106.

63.马艳, 周晓莉, 乔平平, 等. 痛风通络剂联合青鹏膏剂治疗急性痛风关节炎临床观察[J]. 临床医药文献电子杂志, 2020, 7(43): 150-151. [Ma Y, Zhou XL, Qiao PP, et al. Clinical observation on the treatment of acute gouty arthritis with gout tongluo agent combined with Qingpeng ointment[J]. Electronic Journal of Clinical Medical Literature, 2020, 7(43): 150-151.] DOI: 10.16281/j.cnki.jocml.2020.43.098.

64.贺文忠. 蒙药治疗痛风性关节炎的临床疗效[J]. 中国民族医药杂志, 2020, 26(2): 8-9, 12. [He WZ. Clinical efficacy of Mongolian medicine in the treatment of gouty arthritis[J]. Journal of Medicine & Pharmacy of Chinese Minorities, 2020, 26(2): 8-9, 12.] DOI: 10.16041/j.cnki.cn15-1175.2020.02.006.

65.曾翠琼, 黄汉儒. 壮医葫芦茶除痹汤治疗急性痛风性关节炎的临床观察[J]. 中国民族医药杂志, 2017, 23(3): 1-4. [Zeng  CQ, Huang HR. Clinical observation of using Hulucha Chubi decoction to treat acute gout arthritis[J]. Journal of Medicine and Pharmacy of Chinese Minorities, 2017, 23(3): 1-4.] DOI: 10.16041/j.cnki.cn15-1175.2017.03.001.